Due to the known increased CD44 expression in cancer cells [30], a study conducted on bladder cancer by Liu et al. (2023) showed that patients presenting with high CD44 levels, have a poor prognosis [59]. This evidence concerns the gene CD44 and urinary bladder carcinoma.